Financial Times FT.com

Novartis/Nestle may see cycle of negotiations over Alcon option rights in 4Q 2009

By Sasha Damouni, James Avallone and Nadia Damouni

Published: February 10 2009 13:35 | Last updated: February 10 2009 13:35

Email options

The information entered on this page will not be used to send unsolicited email, and will not be sold to a 3rd party.Terms of use |Privacy policy

* required fields



(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)